CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C12004 | BRD-K30382953 | BRD-K30382953 | -- | -- | -- | Details |
C12005 | BRD-K30393343 | BRD-K30393343 | -- | -- | -- | Details |
C12006 | BRD-K30398452 | BRD-K30398452 | -- | -- | -- | Details |
C12007 | BRD-K30402907 | BRD-K30402907 | -- | -- | -- | Details |
C12008 | BRD-K30403168 | BRD-K30403168 | -- | -- | -- | Details |
C12009 | BRD-K30409687 | BRD-K30409687 | -- | -- | -- | Details |
C12010 | BRD-K30415102 | BRD-K30415102 | -- | -- | -- | Details |
C12011 | BRD-K30418433 | BRD-K30418433 | -- | -- | -- | Details |
C12012 | BRD-K30421593 | timolol | ADRB1; ADRB2 | Adrenergic receptor antagonist | timolol-maleate | Details |
C12013 | BRD-K30433551 | BRD-K30433551 | -- | -- | -- | Details |
C12014 | BRD-K30434763 | BRD-K30434763 | -- | -- | -- | Details |
C12015 | BRD-K30436233 | BRD-K30436233 | -- | -- | -- | Details |
C12016 | BRD-K30436657 | BRD-K30436657 | -- | -- | -- | Details |
C12017 | BRD-K30437434 | BRD-K30437434 | -- | -- | -- | Details |
C12018 | BRD-K30437804 | BRD-K30437804 | -- | -- | -- | Details |
C12019 | BRD-K30438246 | BRD-K30438246 | -- | -- | -- | Details |
C12020 | BRD-K30443205 | BRD-K30443205 | -- | -- | -- | Details |
C12021 | BRD-K30446755 | BRD-K30446755 | -- | -- | -- | Details |
C12022 | BRD-K30456673 | BRD-K30456673 | -- | -- | -- | Details |
C12023 | BRD-K30459086 | BRD-K30459086 | -- | -- | -- | Details |
C12024 | BRD-K30462643 | BRD-K30462643 | -- | -- | -- | Details |
C12025 | BRD-K30463976 | BRD-K30463976 | -- | -- | -- | Details |
C12026 | BRD-K30466858 | ellagic-acid | CA14; SYK; CA2; CA4; CA6; CA9; CA12 | HCV inhibitor; HIV integrase inhibitor; Beta-secretase inhibitor; Aldose reductase inhibitor; Reverse transcriptase inhibitor; Glutathione transferase inhibitor; Quorum sensing signaling modulator | -- | Details |
C12027 | BRD-K30467307 | BRD-K30467307 | -- | -- | -- | Details |
C12028 | BRD-K30468438 | BRD-K30468438 | -- | -- | -- | Details |
C12029 | BRD-K30468800 | BRD-K30468800 | -- | -- | -- | Details |
C12030 | BRD-K30477337 | BRD-K30477337 | -- | -- | -- | Details |
C12031 | BRD-K30478013 | BRD-K30478013 | -- | -- | -- | Details |
C12032 | BRD-K30480208 | torasemide | SLC12A1 | Thromboxane receptor antagonist; Electrolyte reabsorption inhibitor | -- | Details |
C12033 | BRD-K30488928 | BRD-K30488928 | -- | -- | -- | Details |
C12034 | BRD-K30491662 | BRD-K30491662 | -- | -- | -- | Details |
C12035 | BRD-K30492965 | BRD-K30492965 | -- | -- | -- | Details |
C12036 | BRD-K30507268 | BRD-K30507268 | -- | -- | -- | Details |
C12037 | BRD-K30509186 | BRD-K30509186 | -- | -- | -- | Details |
C12038 | BRD-K30510226 | BRD-K30510226 | -- | -- | -- | Details |
C12039 | BRD-K30511626 | BRD-K30511626 | -- | -- | -- | Details |
C12040 | BRD-K30516885 | BRD-K30516885 | -- | -- | -- | Details |
C12041 | BRD-K30519779 | homoquinolinic-acid | -- | -- | -- | Details |
C12042 | BRD-K30520487 | BRD-K30520487 | -- | -- | -- | Details |
C12043 | BRD-K30523950 | BRD-K30523950 | -- | -- | -- | Details |
C12044 | BRD-K30530468 | BRD-K30530468 | -- | -- | -- | Details |
C12045 | BRD-K30533903 | BRD-K30533903 | -- | -- | -- | Details |
C12046 | BRD-K30536692 | BRD-K30536692 | -- | -- | -- | Details |
C12047 | BRD-K30545681 | ST-4070169 | -- | -- | -- | Details |
C12048 | BRD-K30548577 | BRD-K30548577 | -- | -- | -- | Details |
C12049 | BRD-K30548766 | BRD-K30548766 | -- | -- | -- | Details |
C12050 | BRD-K30550578 | PF-04620110 | DGAT1 | Diacylglycerol O acyltransferase inhibitor | -- | Details |
C12051 | BRD-K30551445 | BRD-K30551445 | -- | -- | -- | Details |
C12052 | BRD-K30553453 | hesperetin | -- | -- | -- | Details |
C12053 | BRD-K30553817 | BRD-K30553817 | -- | -- | -- | Details |
C12054 | BRD-K30558628 | BRD-K30558628 | -- | -- | -- | Details |
C12055 | BRD-K30563122 | BRD-K30563122 | -- | -- | -- | Details |
C12056 | BRD-K30563334 | rifabutin | -- | -- | -- | Details |
C12057 | BRD-K30563708 | BRD-K30563708 | -- | -- | -- | Details |
C12058 | BRD-K30563791 | BRD-K30563791 | -- | -- | -- | Details |
C12059 | BRD-K30566330 | BRD-K30566330 | -- | -- | -- | Details |
C12060 | BRD-K30570479 | VU-0400195-3 | GRM4 | Glutamate receptor modulator | -- | Details |
C12061 | BRD-K30571172 | BRD-K30571172 | -- | -- | -- | Details |
C12062 | BRD-K30572193 | CTEP | GRM5 | Glutamate receptor antagonist | ctep | Details |
C12063 | BRD-K30573524 | BRD-K30573524 | -- | -- | -- | Details |
C12064 | BRD-K30577245 | docetaxel | TUBB | Tubulin inhibitor | docetaxil | Details |
C12065 | BRD-K30581008 | BRD-K30581008 | -- | -- | -- | Details |
C12066 | BRD-K30589514 | BRD-K30589514 | -- | -- | -- | Details |
C12067 | BRD-K30594227 | BRD-K30594227 | -- | -- | -- | Details |
C12068 | BRD-K30597925 | BRD-K30597925 | -- | -- | -- | Details |
C12069 | BRD-K30600059 | BRD-K30600059 | -- | -- | -- | Details |
C12070 | BRD-K30600766 | amphotericin-b | -- | -- | -- | Details |
C12071 | BRD-K30601921 | BRD-K30601921 | -- | -- | -- | Details |
C12072 | BRD-K30606628 | KU-C104233 | -- | -- | -- | Details |
C12073 | BRD-K30611309 | BRD-K30611309 | -- | -- | -- | Details |
C12074 | BRD-K30612446 | BRD-K30612446 | -- | -- | -- | Details |
C12075 | BRD-K30613842 | BRD-K30613842 | -- | -- | -- | Details |
C12076 | BRD-K30615964 | BRD-K30615964 | -- | -- | -- | Details |
C12077 | BRD-K30618791 | docetaxel | TUBB | Tubulin inhibitor | -- | Details |
C12078 | BRD-K30620974 | BRD-K30620974 | -- | -- | -- | Details |
C12079 | BRD-K30625175 | BRD-K30625175 | -- | -- | -- | Details |
C12080 | BRD-K30628727 | BRD-K30628727 | -- | -- | -- | Details |
C12081 | BRD-K30628839 | BRD-K30628839 | -- | -- | -- | Details |
C12082 | BRD-K30632097 | BRD-K30632097 | -- | -- | -- | Details |
C12083 | BRD-K30632436 | CTB | -- | -- | -- | Details |
C12084 | BRD-K30633507 | BRD-K30633507 | -- | -- | -- | Details |
C12085 | BRD-K30633722 | BRD-K30633722 | -- | -- | -- | Details |
C12086 | BRD-K30634073 | levallorphan | OPRM1 | Opioid antagonist | -- | Details |
C12087 | BRD-K30635390 | BRD-K30635390 | -- | -- | -- | Details |
C12088 | BRD-K30640165 | BRD-K30640165 | -- | -- | -- | Details |
C12089 | BRD-K30643363 | BRD-K30643363 | -- | -- | -- | Details |
C12090 | BRD-K30644784 | BRD-K30644784 | -- | -- | -- | Details |
C12091 | BRD-K30645599 | BRD-K30645599 | -- | -- | -- | Details |
C12092 | BRD-K30647638 | BRD-K30647638 | -- | -- | -- | Details |
C12093 | BRD-K30649361 | BRD-K30649361 | -- | -- | -- | Details |
C12094 | BRD-K30649484 | mafenide | CA6 | Carbonic anhydrase inhibitor | -- | Details |
C12095 | BRD-K30653168 | BRD-K30653168 | -- | -- | -- | Details |
C12096 | BRD-K30655307 | BRD-K30655307 | -- | -- | -- | Details |
C12097 | BRD-K30656344 | BRD-K30656344 | -- | -- | -- | Details |
C12098 | BRD-K30658064 | BRD-K30658064 | -- | -- | -- | Details |
C12099 | BRD-K30659453 | BRD-K30659453 | -- | -- | -- | Details |
C12100 | BRD-K30661365 | BRD-K30661365 | -- | -- | -- | Details |
C12101 | BRD-K30674442 | BRD-K30674442 | -- | -- | -- | Details |
C12102 | BRD-K30674856 | BRD-K30674856 | -- | -- | -- | Details |
C12103 | BRD-K30677119 | PP-30 | RAF1 | RAF inhibitor | -- | Details |